Ardelyx (ARDX) has a profit margin of -12.35%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Ardelyx (ARDX) currently reports a profit margin of -12.35% as of June 2026. That compares with -14.6% in the prior-year period — up 15.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Ardelyx's profit margin history and peer comparisons.
Ardelyx's profit margin increased from -14.6% to -12.35% — a 15.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Ardelyx's profit margin of -12.35% is lower than the Healthcare sector average of 13.89%. That is roughly 188.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Ardelyx's current -12.35% should be judged against Healthcare norms (sector average: 13.89%) and against ARDX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -12.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Ardelyx, and consider following ARDX for alerts when major investors trade the stock.